Hanson McClain Advisors »

Cartesian Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $775 126 6.15
2025-06-30 $156 15 10.40

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds State Street Spd (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Hanson McClain Advisors

Top funds holding Cartesian Therapeutics

Squarepoint Ops
FMR
BlackRock
Vanguard Capital Management
683 Capital Management
Millennium Management
Geode Capital Management
Marshall Wace
Erste Asset Management GmbH
State Street Corporation
Privium Fund Management B.V.
Two Sigma Investments
UBS Group
Citadel Advisors
Jacobs Levy Equity Management

View all funds holding Cartesian Therapeutics